LMP1- and LMP2-Specific CTLs to Patients With EBV-Positive NPC (NATELLA)

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborators:
Houston Methodist Hospital
Texas Children's Hospital
Center for Cell and Gene Therapy, Baylor College of Medicine
Information provided by (Responsible Party):
Stephen Gottschalk, Baylor College of Medicine
ClinicalTrials.gov Identifier:
NCT00516087
First received: August 10, 2007
Last updated: February 14, 2014
Last verified: February 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: August 2022
  Estimated Primary Completion Date: August 2022 (Final data collection date for primary outcome measure)